Mark Baxter

Then they'll go back in again.

And so there's quite an actual process of kind of in and out as they do that work.

And the qualities of MDMA are really ideal to help a person go through that process.

Then the next day we meet for an integration session.

So we're trying to make sense of, map out what happened, but also start to embed what happened into their everyday life.

MDMA opens this critical window for a couple of weeks after where people can make changes.

and work in their life and their belief systems and their habits and patterns in a way that they can't normally.

So it gives us this kind of window of opportunity.

And we have three integration sessions after a dosing day.

And then we go again.

So second dosing day, then three integration sessions, and then third dosing day, three integration sessions.

So we've got

Lots of integration sessions, three dosing days and about four months or five months to work together.

And it builds on each other each session.

You said something about compounding before, which is in therapy, which is really the key here.

We're compounding these insight, this self-perspective, this self-compassion, and also the nervous system stuff I talked about in the MDR as well.

Yeah.

Psilocybin is different, where that's mostly, not always, but mostly a more internal experience.

And that connects people to often larger feelings of connectedness, to loved ones, to self, to nature, to the cosmos, to universe, to big things, to spiritual things sometimes.

can give people an expanded perspective on their life, can take people back into, you know, memories and experiences and have them kind of re-experience that but in a kind of a new way.